DDAVP Nasal Spray — Class I drug recall D-1504-2020
Terminated recall by Ferring Pharmaceuticals Inc, reported 2020-08-26, distributed nationwide. Superpotent Drug
| Recall number | D-1504-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ferring Pharmaceuticals Inc, Parsippany, NJ, United States |
| Recall initiated | 2020-07-21 |
| Classified | 2020-08-17 |
| Reported by FDA | 2020-08-26 |
| Terminated | 2023-10-13 |
| Distributed | Nationwide (US) |
| Quantity | 15,175 nasal |
| Reason classes | potency |
| NDC | 55566-2500-00 |
| Lot numbers | N14695F, N15627C, P11319P, P11706F, R11842C, R13637E |
| Expiration dates | 2020-08, 2020-10, 2021-01, 2021-04, 2022-03, 2022-06 |
Product
DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0
Reason for recall
Superpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1504-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.